Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats

Toxicology

Volumn 190, Issue 3, 2003, Pages 221-230

  Shaikh, Jamaluddin ^a   Pope, Carey N ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Acetylcholinesterase inhibition; Blood brain barrier; Carboxylesterase inhibition; Gulf War Illness; Paraoxon; Pyridostigmine; Treadmill

Indexed keywords

ORGANOPHOSPHATE INSECTICIDE; PARAOXON; PYRIDOSTIGMINE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD COMPONENT; BRAIN REGION; CHOLINERGIC ACTIVITY; CHOLINESTERASE INHIBITION; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; DIAPHRAGM MUSCLE; EVALUATION; EXERCISE TEST; EXPERIMENTAL MODEL; EXPOSURE; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TREADMILL;

EID: 0041632188     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00187-2     Document Type: Article

References (60)

1. Abdel-Rahman A., Shetty A.K., Abou-Donia M.B. Distribution of blood-brain barrier and neuronal cell death in cingulated cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War Syndrome. Neurobiol. Dis. 10:2002;306-326.
2. Abou-Donia M.B., Jensen K.F., Oehme F.W., Kurt T.L., Wilmarth K.R. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: implications of Gulf War chemical exposures. J. Toxicol. Environ. Health. 48:1996;35-56.
3. Abou-Donia M.B., Goldstein L.B., Dechovskaia A., Bullman S., Jones K.H., Herrick E.A., Abdel-Rahman A.A., Khan W.A. Effects of daily dermal application of DEET and permethrin, alone or combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in rats. J. Toxicol. Environ. Health A. 62:2001;523-541.
4. Aldridge W.N. Serum esterase. I. Two types of esterase (A and B) hydrolyzing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem. J. 53:1953;110-117.
5. Ashani Y., Catravas G.N. Seizure-induced changes in the permeability of the blood-brain barrier following administration of anticholinesterase drugs to rats. Biochem. Pharmacol. 30:1981;2593-2601.
6. Ben-Nathan D., Lustig S., Danenberg H.D. Stressed-induced neuroinvasiveness of a neurovirulent noninvasive Sindi virus in cold or isolation subjected mice. Life Sci. 48:1991;1493-1500.
7. Carpentier P., Delamanche I.S., Le Bert M., Blanchet G., Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology. 11:1990;493-508.
8. Chambers H., Brown B., Chambers J.E. Noncatalytic detoxification of six organophosphorus compounds by rat liver homogenates. Pest. Biochem. Physiol. 36:1990;308-315.
9. Clement J.G. Role of aliesterase in organophosphate poisoning. Fundam. Appl. Toxicol. 4:1984;S96-S105.
10. Clement J.G., Erhardt N. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide). Arch. Toxicol. 64:1990;414-416.
11. Ellin R.I., Kaminskis A. Carbamoylated enzyme reversal as a means of predicting pyridostigmine protection against soman. J. Pharm. Pharmacol. 41:1989;633-636.
12. Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain barrier through activation of brain mast cells. Brain Res. 888:2001;117-127.
13. Fonnum F., Sterri S.H. Factors modifying the toxicity of organophosphorus compounds including soman and sarin. Fundam. Appl. Toxicol. 1:1981;143-147.
14. Fonnum F., Sterri S.H., Aas P., Johnsen H. Carboxylesterases: importance for detoxification of organophosphorus anticholinesterases and trichothecenes. Fundam. Appl. Toxicol. 5:1985;S29-S38.
15. Frequin S.T., Barkhof F., Lamers K.J., Hommes O.R. The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis. J. Neuroimmunol. 40:1992;265-272.
16. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2:1996;1382-1385.
17. Fukuto T.R. Mechanism of action of organophosphorus and carbamate insecticides. Environ. Health Perspect. 87:1990;245-254.
18. 3H]dopa in various regions of the brain. J. Neurochem. 13:1966;655-669.
19. Goldstein G., Beers S.R., Marrow L.A., Shemansky W.J., Steinhauer S.R. A preliminary neuropsychological study of Persian Gulf veterans. J. Int. Neuropsychol. Soc. 2:1996;368-371.
20. Grange-Messent V., Bouchaud C., Jamme M., Lallement G., Foquin A., Carpentier P. Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations. Cell. Mol. Biol. (Noisy-le-grand). 45:1999;1-14.
21. Grauer E., Alkalai D., Kapon J., Cohen G., Raveh L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol. Appl. Pharmacol. 164:2000;301-304.
22. Gunderson H., Wehmeyer N., Burnett D., Nauman J., Hartzell C., Savage S. Exercise and exhaustion effects on glycogen synthesis pathways. J. Appl. Physiol. 81:1996;2020-2026.
23. Haley R.W., Kurt T.L. Self-report exposure to neurotoxic chemical combinations in the Gulf War. J. Am. Med. Assoc. 277:1997;231-237.
24. Haley R.W., Horn J., Roland P.S., Bryan W.W., Van Ness P.C. Evaluation of neurologic function in Gulf War veterans. J. Am. Med. Assoc. 277:1997;223-230.
25. Hanin I. The Gulf War, stress and a leaky blood-brain barrier. Nat. Med. 2:1996;1307-1308.
26. Jamal G.A., Hansen S., Apartopoulos F., Peden A. The "Gulf War Syndrome." Is there evidence of dysfunction in the nervous system? J. Neurol. Neurosurg. Psychol. 60:1996;449-451.
27. Johansson B.B., Owman C., Widner H. Physiology of the Blood-Brain Barrier. 1990;Elsevier, Amsterdam.
28. Johnson C.D., Russell R.L. A rapid simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64:1975;229-238.
29. Jokanovic M., Kosanovic M., Maksimovic M. Interaction of organophosphorus compounds with carboxylesterases in the rat. Arch. Toxicol. 70:1996;444-450.
30. Kant G.J., Bauman R.A., Feaster S.R., Anderson S.M., Saviolakis G.A., Garcia G.E. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Pharmacol. Biochem. Behav. 70:2001;209-218.
31. Karanth S., Olivier K., Liu J., Pope C. In vitro interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome. Toxicol. Appl. Pharmacol. 177:2001;247-255.
32. Lallement G., Veyret J., Masqueliez C., Aubriot S., Burckhart M.F., Baubichon D. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam. Clin. Pharmacol. 11:1997;387-394.
33. Lallement G., Foquin A., Baubichon D., Burckhart M.F., Carpentier P., Canini F. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs. Neurotoxicology. 19:1998;759-766.
34. Landrigan P.J. Illness in Gulf War veterans: causes and consequences. J. Am. Med. Assoc. 277:1997;259-261.
35. 3H]hemicholinium-3 binding in rat brain. Fundam. Appl. Toxicol. 34:1996;84-90.
36. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall J.R. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
37. Lundy P.M. Stress and the production of CNS effects of pyridostigmine: a commentary. Am. Soc. Anesthesiologists Newslett. 62:1997;17-19.
38. Mao V.H., Abaza M., Spiegel J.R., Mandel S., Hawkshaw M., Hever R.J., Sataloff R.T. Laryngeal myasthenia gravis: report of 40 cases. J. Voice. 15:2001;122-130.
39. Maxwell D. The specificity of carboxylestarase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114:1992;306-312.
40. Maxwell D.M., Brecht K.M., Doctor B.P., Wolfe A.D. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase. J. Pharmacol. Exp. Ther. 264:1993;1085-1089.
41. McCain W.C., Lee R., Johnson M.S., Whaley J.E., Ferguson J.W., Beall P., Leach G. Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat. J. Toxicol. Environ. Health. 50:1997;113-124.
42. Moser V.C., McCormic J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 11:1988;189-206.
43. Nisenbaum R., Barrett D.H., Reyes M., Reeves W.C. Deployment stressors and a chronic multisymptom illness among Gulf War veterans. J. Nerv. Ment. Dis. 188:2000;259-266.
44. Nostrandt A.C., Duncan J.A., Padilla S. A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 21:1993;196-203.
45. Ovadia H., Abramsky O., Feldman S., Weidenfeld J. Evaluation of the effect of stress on the blood-brain barrier: critical role of the brain perfusion time. Brain Res. 905:2001;21-25.
46. Padilla, S., Hooper, M.J., 1992. Cholinesterase measurements in tissues from carbamate-treated animals: cautions and recommendations. In: Proceedings of the U.S. EPA Workshop on Cholinesterase Methodologies, Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC.
47. Petrali J.P., Maxwell D.M., Lenz D.E., Mills K.R. Effect of an anticholinesterase compound on the ultrastructure and function of the rat blood-brain barrier: a review and experiment. J. Submicrosc. Cytol. Pathol. 23:1991;331-338.
48. Rapoport S.I. Blood-brain barrier in physiology and medicine. 1976;Raven, New York.
49. Riviere J.E., Baynes R.E., Brooks J.D., Yeatts J.L., Monteiro-Riviere N.A. Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. J. Toxicol. Environ. Health A. 66:2003;133-151.
50. Sharma H.S., Cervos-Navarro J., Dey P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10:1991;211-221.
51. Sharma H.S., Nyberg F., Cervos-Navarro J., Dey P.K. Histamine modulates heat stress-induced changes in blood-brain barrier permeability, cerebral blood flow, brain oedema and serotonin levels: an experimental study in conscious young rats. Neuroscience. 50:1992;445-454.
52. 131I-sodium tracers in the rat. Behav. Brain Res. 72:1996;189-196.
53. Sinton C.M., Fitch T.E., Petty F., Haley R.W. Stressful manipulations that elevate corticosterone reduced blood-brain barrier permeability to pyridostigmine in the rat. Toxicol. Appl. Pharmacol. 165:2000;99-105.
54. Song X., Tian H., Bressler J., Pruett S., Pope C.N. Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicol. Sci. 69:2002;157-164.
55. Stahel P.F., Shohami E., Younis F.M., Kariya K., Otto V.I., Lenzlinger P.M., Grosjean M.B., Eugster H.P., Trentz O., Kossmann T., Morganti-Kossmann M.C. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20:2000;369-380.
56. Tang J., Chambers J.E. Detoxification of paraoxon by rat liver homogenate and serum carboxylesterases and A-esterases. J. Biochem. Mol. Toxicol. 13:1999;261-268.
57. Taylor, P., 1990. Cholinergic agonist and Anticholinesterase agents. In: Gilman, A.G., Rall, T.W., Niles, A.S., Taylor, P. (Eds.), The Pharmacological Basis of Therapeutics, 8th ed., Pergamon Press, New York, pp. 122-130, 131-147.
58. Tian H., Song X., Bressler J., Pruett S., Pope C.N. Neither forced running nor forced swimming affect acute pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicology. 176:2002;39-50.
59. van Amelsvoort T., Murphy D.G., Robertson D., Daly E., Whitehead M., Abel K. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. Psychoneuroendocrinology. 28:2003;101-112.
60. Yang Z.P., Dettbarn W. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors. Biochem. Pharmacol. 55:1998;1419-1426.